Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition.

Reife RA, Coats SR, Al-Qutub M, Dixon DM, Braham PA, Billharz RJ, Howald WN, Darveau RP.

Cell Microbiol. 2006 May;8(5):857-68.

PMID:
16611234
2.
3.
4.

Commensal bacteria influence innate status within gingival tissues: a pilot study.

Dixon DR, Reife RA, Cebra JJ, Darveau RP.

J Periodontol. 2004 Nov;75(11):1486-92.

PMID:
15633325
5.

Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM.

Infect Immun. 2004 Sep;72(9):5041-51.

6.
7.

Autoreactivity against matrilin-1 in a patient with relapsing polychondritis.

Buckner JH, Wu JJ, Reife RA, Terato K, Eyre DR.

Arthritis Rheum. 2000 Apr;43(4):939-43.

8.

A study of topiramate pharmacokinetics and tolerability in children with epilepsy.

Rosenfeld WE, Doose DR, Walker SA, Baldassarre JS, Reife RA.

Pediatr Neurol. 1999 May;20(5):339-44.

PMID:
10371378
9.

Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis.

Darveau RP, Belton CM, Reife RA, Lamont RJ.

Infect Immun. 1998 Apr;66(4):1660-5.

10.
11.
12.
13.

Topiramate monotherapy for partial onset seizures.

Sachdeo RC, Reife RA, Lim P, Pledger G.

Epilepsia. 1997 Mar;38(3):294-300.

15.

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.

Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, Karim RM.

Neurology. 1996 Jun;46(6):1684-90.

PMID:
8649570
16.
18.

Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.

Hirose T, Reife RA, Smith GN Jr, Stevens RM, Mainardi CL, Hasty KA.

J Rheumatol. 1992 Apr;19(4):593-9.

PMID:
1317454
19.

Induction of arthritis with monoclonal antibodies to collagen.

Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM.

J Immunol. 1992 Apr 1;148(7):2103-8.

PMID:
1545120
20.

Immunolocalization of metalloproteinases in collagen autoimmune arthritis.

Reife RA, Hasty KA, Mainardi CL, Stuart JM.

Matrix Suppl. 1992;1:397. No abstract available.

PMID:
1480070
21.

SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies.

Reife RA, Loutis N, Watson WC, Hasty KA, Stuart JM.

Arthritis Rheum. 1991 Jun;34(6):776-81.

PMID:
2053925
22.

The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis.

Spinella DG, Jeffers JR, Reife RA, Stuart JM.

Immunogenetics. 1991;34(1):23-7.

PMID:
1855815
23.

The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.

Hasty KA, Reife RA, Kang AH, Stuart JM.

Arthritis Rheum. 1990 Mar;33(3):388-97.

PMID:
2156511
24.

Histochemical and biochemical studies of the hepatopancreas peroxidase of the freshwater crayfish, Cambarus robustus.

Merrill DP, Reife RA, Tiersch TR, Austin RS.

J Morphol. 1985 May;184(2):171-182. doi: 10.1002/jmor.1051840207.

PMID:
29976029

Supplemental Content

Loading ...
Support Center